SEC Filing Summary: Reneo Pharmaceuticals, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Reneo Pharmaceuticals, Inc. (not Onkure Therapeutics, Inc.) on August 11, 2021. The registrant is a Delaware corporation with its principal executive offices in Irvine, California. The company is classified as an emerging growth company and its common stock trades on The Nasdaq Stock Market LLC under the symbol RPHM.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a corporate presentation update rather than a financial results announcement.
Material Changes
There are no material financial changes reported in this document. The sole material event is the update of the Company's corporate slide presentation for use in meetings with investors and analysts.
Guidance, Outlook, and Risks
The filing references an attached corporate slide presentation (Exhibit 99.1) which may contain forward-looking statements, but the text of the 8-K itself does not detail specific guidance, outlook, or risks. The Company explicitly states that the information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that section and shall not be deemed incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is Reneo Pharmaceuticals, Inc. (RPHM), as the input metadata incorrectly referenced Onkure Therapeutics, Inc.
- Review Exhibit 99.1 (Corporate Slide Presentation) directly on the Company's website or via the SEC EDGAR database for specific business updates, as the 8-K text only announces its existence.
- Confirm that any forward-looking statements in the attached presentation are not legally incorporated into this filing.
- Note that no financial performance data is contained within this specific 8-K document.